Kisho is an information platform, not a medical provider. Nothing on this site constitutes medical advice, diagnosis, or treatment recommendations. All content is aggregated from publicly available sources (including ClinicalTrials.gov, PubMed, FDA.gov, and Orphanet) and is provided for informational purposes only. Clinical trial eligibility, treatment decisions, and any health-related actions should always be discussed with a qualified healthcare professional. Kisho does not endorse any specific therapy, organization, or clinical trial. Terms of use · Privacy policy
Sarcoidosis affecting the lung parenchyma. It is characterized by the presence of non-necrotizing granulomas in the lung tissues. It is manifested with dyspnea, cough, fever, night sweats, fatigue, and weight loss.
Biomarker and diagnostic research for pulmonary sarcoidosis has been reported in the published literature.
9 clinical trials registered, 4 recruiting. Interventions under study include drug therapy, other interventions, and medical devices. Pipeline includes 1 PHASE4, 1 PHASE3, 3 PHASE2. Research is sponsored by a mix of industry and academic institutions.
NCT ID | Title | Phase | Sponsor | Status |
|---|---|---|---|---|
[NCT05415137](https://clinicaltrials.gov/study/NCT05415137) |
Data assembled from 3 of 12 sources · Last updated Sep 20, 2026, 10:46 AM UTC
Efficacy and Safety of Intravenous Efzofitimod in Patients With Pulmonary Sarcoidosis |
PHASE3 |
aTyr Pharma, Inc. |
UNKNOWN |
[NCT03755245](https://clinicaltrials.gov/study/NCT03755245) | Biodistribution, Dosimetry and Performance of [68Ga]Ga-DOTA-Siglec-9 in Healthy and Patients With Rheumatoid Arthritis, Vasculitis or Pulmonary Sarcoidosis | NA | Turku University Hospital | ENROLLING_BY_INVITATION |
[NCT06169397](https://clinicaltrials.gov/study/NCT06169397) | An Open-label Extension Study of XTMAB-16 in Patients With Pulmonary Sarcoidosis | PHASE2 | Xentria, Inc. | ACTIVE_NOT_RECRUITING |
[NCT06853834](https://clinicaltrials.gov/study/NCT06853834) | Comparative Diagnostic Yield of Endobronchial Cryo Biopsy vs Forceps Biopsy in Patients With Suspected Sarcoidosis | NA | Sanjay Gandhi Postgraduate Institute of Medical Sciences | RECRUITING |
[NCT05890729](https://clinicaltrials.gov/study/NCT05890729) | A Study of XTMAB-16 in Patients With Pulmonary Sarcoidosis | PHASE1 | Xentria, Inc. | RECRUITING |
207 publications have been identified in PubMed for pulmonary sarcoidosis. Kisho has analyzed 136 by research type. Research spans Review / Meta-Analysis (31%), Epidemiology / Natural History (27%), and Case Report / Case Series (17%).
Research Type | Count | % of Total |
|---|---|---|
Research summaries | 42 | 31% |
Disease patterns and progression | 37 | 27% |
Patient case studies | 23 | 17% |
Testing and diagnosis research | 14 | 10% |
Clinical study results | 9 | 7% |
Laboratory research | 5 | 4% |
Other research | 4 | 3% |
New treatment approaches | 2 | 1% |
Zhao J (2026). [PMID: 41767532](https://pubmed.ncbi.nlm.nih.gov/41767532/). *Front Med (Lausanne)*. [Review / Meta-Analysis]
Van Den Blink B (2026). [PMID: 41819539](https://pubmed.ncbi.nlm.nih.gov/41819539/). *Eur Respir J*. [Clinical Trial Publication]
Kotti N (2026). [PMID: 41963075](https://pubmed.ncbi.nlm.nih.gov/41963075/). *BMJ Open Respir Res*. [Review / Meta-Analysis]
Wang S (2026). [PMID: 42164154](https://pubmed.ncbi.nlm.nih.gov/42164154/). *Front Med (Lausanne)*. [Case Report / Case Series]
Hashim Z (2026). [PMID: 42144146](https://pubmed.ncbi.nlm.nih.gov/42144146/). *Respir Med*. [Review / Meta-Analysis]
Ramos D (2026). [PMID: 41418888](https://pubmed.ncbi.nlm.nih.gov/41418888/). *Respir Med*. [Epidemiology / Natural History]
Ledda RE (2026). [PMID: 41406556](https://pubmed.ncbi.nlm.nih.gov/41406556/). *Curr Opin Immunol*. [Review / Meta-Analysis]
Dhanani Z (2026). [PMID: 42202746](https://pubmed.ncbi.nlm.nih.gov/42202746/). *Curr Opin Immunol*. [Review / Meta-Analysis]
Lotana H (2026). [PMID: 41519022](https://pubmed.ncbi.nlm.nih.gov/41519022/). *Curr Opin Immunol*. [Review / Meta-Analysis]
Yadav R (2026). [PMID: 41794119](https://pubmed.ncbi.nlm.nih.gov/41794119/). *Chest*. [Epidemiology / Natural History]
AI-curated news mentioning pulmonary sarcoidosis
Updated Aug 25, 2026
Recent research highlights the potential of quantitative computed tomography imaging to enhance the assessment of pulmonary sarcoidosis. This approach may improve diagnostic accuracy and monitoring of disease progression.